Investing

RAD receives IND approval from US FDA for Betabart (RV-01)

by admin
RAD receives IND approval from US FDA for Betabart (RV-01)

Radiopharm Theranostics (RAD:AU) has announced RAD receives IND approval from US FDA for Betabart (RV-01)

Download the PDF here.

This post appeared first on investingnews.com

Related Posts

Skyharbour’s Partner Company UraEx Resources Commences Summer 2025...

July 16, 2025

OPINION — Goldenomics 103: Gold Protects and Performs

August 16, 2025

Capital Raise Presentation

August 28, 2025

SAGA Metals Completes Maiden Drill Program and Commences...

April 17, 2025

Nevada Sunrise Closes $650,000 Private Placement

November 7, 2025

LaFleur Minerals Files Amended and Restated Offering Document

August 20, 2025

CHARBONE Hydrogen and ABB Sign Agreement to Advance...

March 14, 2025

Cygnus intersects new high-grade gold, plus visible gold*...

April 17, 2025

Quimbaya Gold

July 9, 2025

Asara Resources

July 8, 2025